NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
NCT05083260
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
NE3107
DRUG:
placebo
Sponsor
BioVie Inc.